Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

3.4K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
3.4K
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

1.3K
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.3K
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

1.4K
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

689
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
689
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

538
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
538
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical outcomes of TAVR with self-expanding valves for non- or minimally calcified aortic regurgitation.

Cardiovascular revascularization medicine : including molecular interventions·2026
Same author

Prognostic Value of Tricuspid Regurgitation in Pulmonary Hypertension and Among the Different WHO Groups.

JACC. Cardiovascular imaging·2026
Same author

Feasibility and Safety of Same-Day Discharge Following Elective Mitral Transcatheter Edge-to-Edge Repair.

JACC. Advances·2026
Same author

Real-World Outcomes of Transcatheter Tricuspid Valve Replacement: Analysis From the STS/ACC TVT Registry.

JAMA·2026
Same author

Hemodynamic and Clinical Outcomes of Transcatheter Valve Expansion in Degenerated Mitral Bioprostheses.

Circulation. Cardiovascular interventions·2026
Same author

Hemodynamic Instability Following Transcatheter Tricuspid Valve Replacement: Red Alert.

JACC. Cardiovascular interventions·2026
Same journal

Incidental Extrinsic Cardiac Compression by a Pericardial Mass: Echocardiographic and CT Correlation.

US cardiology·2026
Same journal

Picking Up the Tempo on Treatment of Combined Post- and Pre-capillary Pulmonary Hypertension: Viewpoint on the CADENCE Trial.

US cardiology·2026
Same journal

Ultrasound-facilitated Catheter-directed Thrombolysis in Intermediate- to High-risk Pulmonary Embolism: Perspectives on the HI-PEITHO Trial.

US cardiology·2026
Same journal

ORBITA-CTO: Isolated at Last, Chronic Total Occlusion Percutaneous Coronary Intervention's True Effect.

US cardiology·2026
Same journal

Heart Failure Wired from Shock to Devices and Home: A New Era of Delivery.

US cardiology·2026
Same journal

Diagnostic Approach to Left Ventricular Hypertrophy: A Review.

US cardiology·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.7K

Transcatheter Tricuspid Valve Intervention: Current Perspective.

Trevor J Simard1, Mackram F Eleid1

  • 1Department of Cardiovascular Medicine, Mayo Clinic School of Medicine Rochester, MN.

US Cardiology
|December 25, 2024
PubMed
Summary
This summary is machine-generated.

Tricuspid regurgitation (TR) negatively affects survival and quality of life. Transcatheter tricuspid valve intervention (TTVI) offers new therapeutic options beyond traditional surgery for TR patients.

Keywords:
TTVITTVRTricuspid regurgitationtranscatheter

More Related Videos

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

2.5K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.7K

Related Experiment Videos

Last Updated: May 5, 2026

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
08:31

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair

Published on: October 16, 2021

3.7K
Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement
09:57

Four-Dimensional Computed Tomography-Guided Valve Sizing for Transcatheter Pulmonary Valve Replacement

Published on: January 20, 2022

2.5K
Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

2.7K

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Cardiac Surgery

Background:

  • Tricuspid regurgitation (TR) significantly impairs patient quality of life and long-term survival.
  • Traditional surgical TR treatments carry high risks, especially for elderly patients with comorbidities.
  • Limited therapeutic options for TR have driven innovation in minimally invasive approaches.

Purpose of the Study:

  • To review the current landscape of transcatheter tricuspid valve intervention (TTVI) strategies.
  • To provide an overview of emerging TTVI techniques for managing tricuspid regurgitation.

Main Methods:

  • Review of current transcatheter tricuspid valve intervention (TTVI) approaches.
  • Discussion of various TTVI strategies, including edge-to-edge repair, annular reduction, spacers, caval valve implantation, and valve replacement.

Main Results:

  • Transcatheter tricuspid valve intervention (TTVI) represents a rapidly evolving field.
  • Early results indicate that TTVI approaches can improve clinical outcomes in TR patients.
  • A variety of TTVI strategies are currently being pursued.

Conclusions:

  • Transcatheter tricuspid valve intervention (TTVI) is expanding therapeutic options for tricuspid regurgitation.
  • TTVI offers a promising alternative to surgery, particularly for high-risk patients.
  • The review details the current status of diverse TTVI methods.